CONtiNuous glucosE Monitoring (CGM) in People wiTh Type 2 Diabetes Not on Insulin
NCT: NCT06601166 · ACTIVE_NOT_RECRUITING
Brief Summary
This multi-center study is a 26-week randomized controlled trial (RCT) in which adults (≥18 years) with type 2 diabetes (T2D) not using insulin and managed in a primary-care setting will be randomly assigned 1:1 to either use of real-time continuous glucose monitoring (CGM) or routine care (RC) plus interval blinded CGM wear.
Frequently Asked Questions
What is CONtiNuous glucosE Monitoring (CGM) in People wiTh Type 2 Diabetes Not on Insulin?
CONtiNuous glucosE Monitoring (CGM) in People wiTh Type 2 Diabetes Not on Insulin is a clinical trial registered under NCT06601166. Current status: ACTIVE_NOT_RECRUITING.
What is the status of NCT06601166?
The current status of NCT06601166 (CONtiNuous glucosE Monitoring (CGM) in People wiTh Type 2 Diabetes Not on Insulin) is: ACTIVE_NOT_RECRUITING.
When did CONtiNuous glucosE Monitoring (CGM) in People wiTh Type 2 Diabetes Not on Insulin start?
CONtiNuous glucosE Monitoring (CGM) in People wiTh Type 2 Diabetes Not on Insulin started on 2024-08-15.
Related Devices
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.